1. Dr Stewart Hay, CEO | www.therapeuticinnovation.com.au | (03) 9670 7018www.therapeuticinnovation.com.au

2. “Facilitated Therapeutic Product Development Pathways” Capabilities Suite of capabilities enabling development of novel health technologies from the laboratory bench into clinical trials 34 centres nationally: Drug discovery, Protein Production, Cell Therapies, Preclinical Testing, Clinical Trials, etc. 6 National Advisory Committees Funding Running $100M in research infrastructure projects. Supporting the Australian Government in ‘Translating Health Discovery into Clinical Application’ Previously funded research lead to 26 Phase I/II clinical trials Institutional Platform Investments into18 hospitals, 11 research institutes & 9 universities Engagement with the pharmaceutical industry, government agencies and comparable international organisations

3. The Aggregation Strategy